In recent years, the tightening of US immigration policies, coupled with increasing pressure on education spending, is ...

Developing innovative drugs is no easy feat. For years, the industry has battled three major pain points: long cycles, staggering costs, and high failure rates. Lengthy pipelines and endless wet-lab ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

Mast and Herper have covered rare disease issues for a combined three decades. As part of the reporting, Mast spent two days ...

Join us for a FREE five day celebration of comics, creativity, and learning. Enjoy engaging panels, workshops, and ...

Researchers cobbled together funding and time to show how quantum computing could aid in the development of drugs to help ...

Live News Mylan Plans to Sell Up to $363 Million Stake in India's Biocon Real-time data enables better timing for trades.